{"nct_id":"NCT04713553","title":"A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants","status":"COMPLETED","status_verified_date":"2022-11","start_date":"2021-02-15","start_date_type":"ACTUAL","primary_completion_date":"2021-07-22","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BNTX"]}